FierceBiotech2d
Big Pharma layoff rounds jump 281% in '24, but overall industry rates similar to '23
Overall, biopharma layoffs rose ever so slightly in 2024 compared to the year before, though the number of layoff rounds ...
Here's what Big Pharma could buy in 2025, from obesity drugs to precision cancer treatments, according to a top M&A banker
Jefferies investment banker Chris Roop discussed the Big Pharma M&A outlook with Business Insider. Check out the types of ...
pharmaphorum3d
Finding the right path: the evolving relationship between small biotech and big pharma
How has the relationship between Big Pharma and biotech evolved? And where do CROs fit into the mix? Dearth of VC funding forcing difficult biotech decisions The realities of the global economy ...